Apathy Cure Through Bupropion in Huntington's Disease
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The influence of bupropion compared to placebo on the change of apathy as quantified by the
apathy evaluation scale (AES-I, where I [informant] is a friend or family member familiar
with the daily activities of the subject) in patients with HD after ten (10) weeks of
treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Charite University, Berlin, Germany
Collaborators:
Ruhr University of Bochum University Hospital Muenster University of Ulm